Company Nanoantibiotics Inc Other OTC
Equities
US63009U1025
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Penelope Markham
PRN | Corporate Officer/Principal | 58 | 18-10-31 |
Sarah Hoit
PRN | Corporate Officer/Principal | 57 | 22-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
Director/Board Member | 65 | 20-06-15 | |
Sigmund Rogich
BRD | Director/Board Member | 80 | 20-06-15 |
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Michael Sherman
BRD | Director/Board Member | 65 | 17-10-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,947,476 | 31,167,893 ( 56.72 %) | 22,880 ( 0.0416 %) | 56.72 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BIVI Stock
- Stock
- Company Nanoantibiotics Inc